Zhimin J. Shao

270 Dong An Road
Shanghai, 200032, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 162 publications

Early identification of PRISm from chest CT: a multimodal for three-class stratification of normal, PRISm, and COPD.

Early identification of PRISm from chest CT: a multimodal for three-class stratification of normal, PRISm, and COPD.

Journal: Frontiers in radiology

Published: March 13, 2026

On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort.

On-treatment core needle biopsy identifies early responders for axillary surgery de-escalation: results from a prospective cohort.

Journal: British journal of cancer

Published: November 02, 2025

A Prospective Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy for Patients With 1 to 10 Brain Metastases From Breast Cancer.

A Prospective Phase 2 Trial of Hypofractionated Stereotactic Radiation Therapy for Patients With 1 to 10 Brain Metastases From Breast Cancer.

Journal: International journal of radiation oncology, biology, physics

Published: August 17, 2025

Early Ki67 change predicts prognosis and supports response-adapted therapy in breast cancer treated with neoadjuvant chemotherapy.

Early Ki67 change predicts prognosis and supports response-adapted therapy in breast cancer treated with neoadjuvant chemotherapy.

Journal: Breast (Edinburgh, Scotland)

Published: August 11, 2025

Current landscape and challenges in autologous breast reconstruction across China: A nationwide questionnaire-based survey of 198 hospitals.

Current landscape and challenges in autologous breast reconstruction across China: A nationwide questionnaire-based survey of 198 hospitals.

Journal: Journal of plastic, reconstructive & aesthetic surgery : JPRAS

Published: August 09, 2025

Predicting rehabilitation outcomes of unilateral stroke after brain-computer interface training based on magnetic resonance imaging data.

Predicting rehabilitation outcomes of unilateral stroke after brain-computer interface training based on magnetic resonance imaging data.

Journal: Medicine

Published: May 19, 2025

A prospective single-center cohort study: integrating PET imaging and genomics to identify early biomarkers of response to dual-targeted PH neoadjuvant therapy in breast cancer.

A prospective single-center cohort study: integrating PET imaging and genomics to identify early biomarkers of response to dual-targeted PH neoadjuvant therapy in breast cancer.

Journal: International journal of surgery (London, England)

Published: April 09, 2025

Erratum: Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial.

Erratum: Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: February 07, 2025

Clinical and molecular characteristics of HER2-low triple-negative breast cancer: insights from multi-omics analysis.

Clinical and molecular characteristics of HER2-low triple-negative breast cancer: insights from multi-omics analysis.

Journal: Breast (Edinburgh, Scotland)

Published: February 02, 2025

Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial.

Adjuvant Atezolizumab for Early Triple-Negative Breast Cancer: The ALEXANDRA/IMpassion030 Randomized Clinical Trial.

Journal: JAMA

Published: January 30, 2025

Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer.

Survival with Trastuzumab Emtansine in Residual HER2-Positive Breast Cancer.

Journal: The New England journal of medicine

Published: January 15, 2025

Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial.

Fulvestrant Versus Anastrozole in Endocrine Therapy-Naïve Women With Hormone Receptor-Positive Advanced Breast Cancer: Final Overall Survival in the Phase III FALCON Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: January 08, 2025

Showing 1-12 of 162

Last Updated: 09/26/2026